Form 4: Tonix Pharmaceuticals Director Reports Involuntary Sale of Fractional Shares After Reverse Stock Split

Richard H. Bagger, a director at Tonix Pharmaceuticals, reported an involuntary sale of 0.02 common stock shares due to a reverse stock split.

Summary

• On February 5, 2025, Richard H. Bagger, a director of Tonix Pharmaceuticals Holding Corp., reported an involuntary sale of 0.02 shares of common stock.
• The sale occurred due to fractional shares resulting from a reverse stock split.
• The price per share was $0.2.
• The transaction was reported on February 28, 2025.

Sentiment

Score: 5

Explanation: The document reports a routine transaction (involuntary sale of fractional shares) following a reverse stock split, which is neither particularly positive nor negative. It's a neutral event.

Industry Context

Reverse stock splits are often used by companies to increase their stock price to meet minimum listing requirements or to make the stock more attractive to investors. The sale of fractional shares resulting from such splits is a common occurrence.

Key Dates